Literature DB >> 11826142

Glutamate receptor-dependent modulation of dopamine efflux in the nucleus accumbens by basolateral, but not central, nucleus of the amygdala in rats.

John G Howland1, Pornnarin Taepavarapruk, Anthony G Phillips.   

Abstract

Dopaminergic neurotransmission in the nucleus accumbens (NAc) and neural processes in the basolateral (BLA) and central (CeN) amygdala nuclei are implicated in associative reward learning. Given their direct and indirect connections with the NAc and ventral tegmental area (VTA), both the BLA and CeN may regulate the mesoaccumbens dopamine (DA) system in rewarding situations. Electrical stimulation of the BLA (20 Hz, 10 sec, 300 microA) induced a long-lasting 25 +/- 4% increase in DA efflux in the NAc, measured by microdialysis in freely moving rats, whereas comparable stimulation of the CeN had no effect. Reverse dialysis of either the NMDA receptor antagonist APV (100 micrometer) or the AMPA-kainate receptor antagonist DNQX (100 micrometer), but not the metabotropic glutamate receptor antagonist (+/-)-amino-4-carboxy-methyl-phenylacetic acid (100 micrometer), into the NAc blocked the stimulation-evoked increase in DA efflux in the NAc. VTA infusion of lidocaine (lido; 4%) significantly reduced basal DA levels for approximately 30 min but failed to suppress the increase in NAc DA efflux resulting from BLA stimulation. Additionally, infusions of lido (4%) into the medial prefrontal cortex failed to block the stimulation-evoked increase in NAc DA efflux. These data support the hypothesis that the BLA can directly modulate DA efflux through local mechanisms in the NAc, independent of an action on DA cell bodies in the VTA. The finding that brief activation of the CeN had no long-lasting effects on DA efflux in the NAc suggests an important degree of functional independence between the CeN and BLA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11826142      PMCID: PMC6758508     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  56 in total

1.  Amygdala regulation of nucleus accumbens dopamine output is governed by the prefrontal cortex.

Authors:  M E Jackson; B Moghaddam
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

2.  NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.

Authors:  A Imperato; M G Scrocco; S Bacchi; L Angelucci
Journal:  Eur J Pharmacol       Date:  1990-10-23       Impact factor: 4.432

3.  Different types of fear-conditioned behaviour mediated by separate nuclei within amygdala.

Authors:  S Killcross; T W Robbins; B J Everitt
Journal:  Nature       Date:  1997-07-24       Impact factor: 49.962

Review 4.  New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata.

Authors:  G F Alheid; L Heimer
Journal:  Neuroscience       Date:  1988-10       Impact factor: 3.590

5.  Hyperlocomotion and increased dopamine efflux in the rat nucleus accumbens evoked by electrical stimulation of the ventral subiculum: role of ionotropic glutamate and dopamine D1 receptors.

Authors:  P Taepavarapruk; S B Floresco; A G Phillips
Journal:  Psychopharmacology (Berl)       Date:  2000-08       Impact factor: 4.530

6.  N-methyl-D-aspartate receptor-dependent plasticity within a distributed corticostriatal network mediates appetitive instrumental learning.

Authors:  A E Baldwin; M R Holahan; K Sadeghian; A E Kelley
Journal:  Behav Neurosci       Date:  2000-02       Impact factor: 1.912

7.  Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin.

Authors:  S R Sesack; A Y Deutch; R H Roth; B S Bunney
Journal:  J Comp Neurol       Date:  1989-12-08       Impact factor: 3.215

8.  Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors.

Authors:  M T Taber; H C Fibiger
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

9.  Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine.

Authors:  J A Parkinson; M C Olmstead; L H Burns; T W Robbins; B J Everitt
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

10.  Effects of excitotoxic lesions of the central amygdaloid nucleus on the potentiation of reward-related stimuli by intra-accumbens amphetamine.

Authors:  P Robledo; T W Robbins; B J Everitt
Journal:  Behav Neurosci       Date:  1996-10       Impact factor: 1.912

View more
  43 in total

1.  Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization.

Authors:  Shoshana Eitan; Camron D Bryant; Nazli Saliminejad; Yu C Yang; Elroy Vojdani; Duane Keith; Roberto Polakiewicz; Christopher J Evans
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

Review 2.  Emerging, reemerging, and forgotten brain areas of the reward circuit: Notes from the 2010 Motivational Neural Networks conference.

Authors:  Vincent B McGinty; Benjamin Y Hayden; Sarah R Heilbronner; Eric C Dumont; Steven M Graves; Martine M Mirrione; Johann du Hoffmann; Gregory C Sartor; Rodrigo A España; E Zayra Millan; Alexandra G Difeliceantonio; Nathan J Marchant; T Celeste Napier; David H Root; Stephanie L Borgland; Michael T Treadway; Stan B Floresco; Jacqueline F McGinty; Suzanne Haber
Journal:  Behav Brain Res       Date:  2011-07-26       Impact factor: 3.332

Review 3.  Monitoring rapid chemical communication in the brain.

Authors:  Donita L Robinson; Andre Hermans; Andrew T Seipel; R Mark Wightman
Journal:  Chem Rev       Date:  2008-06-25       Impact factor: 60.622

4.  Transient viral-mediated overexpression of alpha-calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell leads to long-lasting functional upregulation of alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors: dopamine type-1 receptor and protein kinase A dependence.

Authors:  B F Singer; J A Loweth; R L Neve; P Vezina
Journal:  Eur J Neurosci       Date:  2010-03-19       Impact factor: 3.386

5.  Sources contributing to the average extracellular concentration of dopamine in the nucleus accumbens.

Authors:  Catarina A Owesson-White; Mitchell F Roitman; Leslie A Sombers; Anna M Belle; Richard B Keithley; Jessica L Peele; Regina M Carelli; R Mark Wightman
Journal:  J Neurochem       Date:  2012-03-13       Impact factor: 5.372

6.  Elevated glucose metabolism in the amygdala during an inhibitory avoidance task.

Authors:  Leslie A Sandusky; Robert W Flint; Ewan C McNay
Journal:  Behav Brain Res       Date:  2013-02-15       Impact factor: 3.332

7.  Ventral tegmental area α6β2 nicotinic acetylcholine receptors modulate phasic dopamine release in the nucleus accumbens core.

Authors:  Robert Wickham; Wojciech Solecki; Liza Rathbun; J Michael McIntosh; Nii A Addy
Journal:  Psychopharmacology (Berl)       Date:  2013-04-30       Impact factor: 4.530

8.  Region-specific contribution of the ventral tegmental area to heroin-induced conditioned immunomodulation.

Authors:  Lee W Hutson; Jennifer L Szczytkowski; Timothy B Saurer; Christina Lebonville; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2014-01-24       Impact factor: 7.217

9.  Basal and cocaine-induced sex differences in the DARPP-32-mediated signaling pathway.

Authors:  Luyi Zhou; Arbi Nazarian; Wei-Lun Sun; Shirzad Jenab; Vanya Quinones-Jenab
Journal:  Psychopharmacology (Berl)       Date:  2008-11-05       Impact factor: 4.530

10.  Basolateral amygdala neurons facilitate reward-seeking behavior by exciting nucleus accumbens neurons.

Authors:  Frederic Ambroggi; Akinori Ishikawa; Howard L Fields; Saleem M Nicola
Journal:  Neuron       Date:  2008-08-28       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.